Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Charlton Aria Acquisition Unit | CHARU | Nov 1, 2024 | 9.98 | 0.00 |
Chart Industries | GTLS-B | Nov 1, 2024 | 52.46 | +6.30 |
Chart Industries | GTLS | Nov 1, 2024 | 130.00 | +7.69 |
Charter Communications A | CHTR | Nov 1, 2024 | 366.49 | +11.87 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Nov 1, 2024 | 23.33 | -0.72 |
Chatham Lodging Trust REIT | CLDT | Nov 1, 2024 | 7.86 | -0.51 |
Cheche Group | CCG | Nov 1, 2024 | 0.78 | +0.38 |
Check Point Software Technolgies | CHKP | Nov 1, 2024 | 170.50 | -1.56 |
Check-Cap | CHEK | Nov 1, 2024 | 1.15 | +3.60 |
Checkpoint Therapeutics | CKPT | Nov 1, 2024 | 3.51 | +2.03 |
Cheer Holding | CHR | Nov 1, 2024 | 2.77 | -3.82 |
Cheetah Mobile ADR | CMCM | Nov 1, 2024 | 4.38 | +3.55 |
Cheetah Net Supply Chain Service | CTNT | Nov 1, 2024 | 2.58 | -8.99 |
Chegg | CHGG | Nov 1, 2024 | 1.63 | +1.88 |
Chemed | CHE | Nov 1, 2024 | 531.68 | -1.58 |
Chemomab Therapeutics ADR | CMMB | Nov 1, 2024 | 1.38 | -2.82 |
Chemours | CC | Nov 1, 2024 | 17.82 | -1.87 |
Chemung Financial | CHMG | Nov 1, 2024 | 47.31 | -0.98 |
Chenghe Acquisition I Co A | LATG | Nov 1, 2024 | 11.66 | 0.00 |
Chenghe Acquisition I Units | LATGU | Nov 1, 2024 | 11.56 | 0.00 |
Chenghe Acquisition II | CHEB | Nov 1, 2024 | 10.03 | 0.00 |
Cheniere Energy | LNG | Nov 1, 2024 | 187.55 | -2.00 |
Cheniere Energy Partners LP Unit | CQP | Nov 1, 2024 | 49.96 | -1.17 |
Cherry Hill Mortgage Investment | CHMI | Nov 1, 2024 | 3.26 | -2.98 |
Cherry Hill Mortgage Investment A Pref | CHMI-A | Nov 1, 2024 | 23.80 | +0.21 |
Cherry Hill Mortgage Investment B Pref | CHMI-B | Nov 1, 2024 | 24.87 | +0.69 |
Chesapeake Utilities | CPK | Nov 1, 2024 | 117.50 | -1.91 |
Chevron | CVX | Nov 1, 2024 | 153.07 | +2.86 |
Chewy A | CHWY | Nov 1, 2024 | 27.12 | +0.56 |
Chicago Atlantic | LIEN | Nov 1, 2024 | 13.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.